The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American Indian/Alaska Native populations, and persons experiencing homelessness.
Continuing Medical Education and Continuing Education (CME/CE) offered at NO COST
Once you register, you will be able to attend any of the monthly webinars. You will not need to register again.